Hangzhou Qihan Biotech Co., Ltd.
globalThis record tracks a ransomware attack claimed by the global group against Hangzhou Qihan Biotech Co., Ltd.. It collects the publicly disclosed attack details — sector, location and timeline — as published on the operator's leak site and indexed by Breach House.
Window Zero
EXPOSURE GAPWindow Zero is the time the breach stayed in the open before anyone said so — the gap between when the attack was first discovered on the operator's leak site (t1) and when it was publicly disclosed (t2). The wider this window, the longer victims, staff and customers were exposed with no warning.
Attack Summary
Qihan Biotech is a Hangzhou‑based biotech company specializing in gene editing and cell/organ therapies. It develops immune‑privileged cells and xenogeneic organs to treat cancer and organ failure. The company aims to make these therapies accessible worldwide.
Leak Screenshots
SAMPLEProof-of-breach screenshots the operator posted from the stolen data. Previews are redacted and locked — the originals are available on HaveIBeenRansom.